BIIB BIOGEN INC Investments/Divestments 8-K Filing 2023 - Credit Agreement for Acquisition Funding Biogen Inc. entered into a Credit Agreement with JPMorgan Chase Bank for a $1.5 billion unsecured term loan facility to fund the acquisition of Reata Pharmaceuticals, Inc.Get access to all SEC 8-K filings of the BIOGEN INC